Updates on Chronic HBV: Current Challenges and Future Goals
Lee HM, Banini BA. Updates on Chronic HBV: Current Challenges and Future Goals. Current Treatment Options In Gastroenterology 2019, 17: 271-291. PMID: 31077059, DOI: 10.1007/s11938-019-00236-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsTenofovir alafenamide fumarateGlobal public health problemPublic health problemChronic HBVHepatocellular carcinomaLiver failureCurative treatmentLiver diseaseAntiviral therapyClinical trialsHealth problemsLaboratory safety parametersNew treatment recommendationsAdvanced liver diseaseComplications of cirrhosisCurrent antiviral therapiesEarly phase studiesLong-term useNucleotide analog drugsHBV reactivationLiver decompensationFunctional cureTherapeutic armamentariumTreatment recommendationsImproved outcomesVitamin E in Nonalcoholic Fatty Liver Disease
Banini B, Sanyal A. Vitamin E in Nonalcoholic Fatty Liver Disease. Nutrition And Health 2019, 311-323. DOI: 10.1007/978-3-030-05315-4_23.ChaptersNonalcoholic fatty liver diseaseVitamin E supplementationChronic liver diseaseFatty liver diseaseNonalcoholic steatohepatitisLiver diseaseE supplementationVitamin ESubtype of NAFLDAnnual direct medical costsChronic viral hepatitisAlcoholic liver diseaseClinical practice guidelinesDirect medical costsLong-term useNAFLD patientsLabel treatmentViral hepatitisPharmacological therapyComplex pathogenesisHistological featuresLiver fibrosisClinical trialsLeading causeClinical studies